Jefferies Maintains Hold on Autoliv, Lowers Price Target to $119
Jefferies analyst Vanessa Jeffriess maintains Autoliv (NYSE:ALV) with a Hold and lowers the price target from $134 to $119.
Stocks · News reference
Analysts downgraded Accelerant, Autoliv, Compass Therapeutics, Wave Life Sciences and PG&E; price targets for CMPX and PCG were cut.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Jefferies analyst Vanessa Jeffriess maintains Autoliv (NYSE:ALV) with a Hold and lowers the price target from $134 to $119.
Wolfe Research analyst Emmanuel Rosner downgrades Autoliv (NYSE:ALV) from Outperform to Peer Perform.
Filed: 2026-09-23 AccNo: 0001997350-26-000018 Size: 194 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Raymond James analyst C. Gregory Peters downgrades Accelerant Hldgs (NYSE:ARX) from Market Perform to Underperform.
Zacks highlights strong stock performance from its various rating systems and portfolios. Accelerant gained 53.7% after a Zacks Rank upgrade, while Shopify and Broadridge Financial gained 28.8% and 19.5% respectively over 12 weeks. General Mills climbed 22.9% as investors favored dividend stocks amid market volatility. The article demonstrates the effectiveness of Zacks' research methodologies across multiple portfolio strategies despite economic headwinds including sticky inflation and slowing consumer confidence.